Two Chemotherapy Regimens Compared With Observation in Treating Patients With Completely Resected Pancreatic Cancer
Status:
Completed
Trial end date:
2010-09-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die. It is not yet known which chemotherapy regimen is more effective,
or whether chemotherapy is more effective than observation, in treating pancreatic cancer
after surgery.
PURPOSE: Phase III trial to compare the effectiveness of two chemotherapy regimens with no
further therapy in treating patients who have completely resected pancreatic cancer.
Phase:
Phase 3
Details
Lead Sponsor:
Royal Liverpool University Hospital
Collaborators:
Australasian Gastro-Intestinal Trials Group NCIC Clinical Trials Group